Pfizer Wins Over Medivation With $14B Buyout
U.S. pharmaceutical giant Pfizer on Monday revealed a $14 billion deal for Medivation, a buyout that comes after the oncology-focused biotech company sought to fight off a takeover from French drugmaker...To view the full article, register now.
Already a subscriber? Click here to view full article